ASTRAZENECA PLC-SPONS ADR (AZN) Stock Price, Quote, News and Overview
NASDAQ:AZN - Nasdaq - US0463531089 - ADR - Currency: USD
AZN Quote, Performance and Key Statistics
ASTRAZENECA PLC-SPONS ADR
NASDAQ:AZN (2/4/2025, 8:00:01 PM)
After market: 68.7972 -0.16 (-0.24%)68.96
-0.9 (-1.29%)
The current stock price of AZN is 68.96 USD. In the past month the price increased by 4.09%. In the past year, price increased by 10.76%.
AZN Latest News, Press Releases and Analysis
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN). Such investors...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN) of a class action securities lawsuit....
AZN Stock News: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the AstraZeneca PLC Class Action
/PRNewswire/ -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired...
AstraZeneca Blames 'Toxic' Climate As It Walks Away from Over $550 Million UK Vaccine Plant
AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing concerns over NHS drug pricing and industry tensions.
AZN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 81.23 | 784.20B | ||
| JNJ | JOHNSON & JOHNSON | 15.36 | 369.55B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.2 | 366.85B | ||
| MRK | MERCK & CO. INC. | 15.25 | 229.54B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.32 | 210.86B | ||
| PFE | PFIZER INC | 10.03 | 146.61B | ||
| SNY | SANOFI-ADR | 14.82 | 134.13B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.53 | 119.91B | ||
| ZTS | ZOETIS INC | 29.9 | 77.71B | ||
| GSK | GSK PLC-SPON ADR | 8.46 | 71.08B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 22.2 | 42.23B | ||
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 6.85 | 19.33B |
Related stock screener links
About AZN
Company Profile
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its biopharmaceuticals products include Farxiga, Crestor, Breztri and others. Its investigational vaccine candidate IVX-A12, which targets both respiratory syncytial virus and human metapneumovirus. Its oncology candidate includes FPI-2265 targeting prostate specific membrane antigen for metastatic castration resistant prostate cancer, which is in a Phase II trial. The company also discovers, develops, and manufactures T-cell receptor therapies. Its Eneboparatide is an investigational therapeutic peptide.
Company Info
ASTRAZENECA PLC-SPONS ADR
1 Francis Crick Avenue, Cambridge Biomedical Campus
CAMBRIDGE CAMBRIDGESHIRE CB2 0AA GB
CEO: Pascal Soriot
Employees: 89900
Company Website: https://www.astrazeneca.com/
Investor Relations: https://www.astrazeneca.com/investor-relations.html
Phone: 442073045000
AZN FAQ
What is the stock price of AZN?
The current stock price of AZN is 68.96 USD.
What is the symbol for ASTRAZENECA PLC-SPONS ADR stock?
The exchange symbol of ASTRAZENECA PLC-SPONS ADR is AZN and it is listed on the Nasdaq exchange.
On which exchange is AZN stock listed?
AZN stock is listed on the Nasdaq exchange.
Is AZN a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for AZN, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of AZN.
Does AZN stock pay dividends?
AZN has a dividend yield of 2.06%. The yearly dividend amount is currently 2.89.
When does AZN stock report earnings?
AZN will report earnings on 2025-02-06, before the market open.
What is the Price/Earnings (PE) ratio of AZN?
The PE ratio for AZN is 18.1. This is based on the reported non-GAAP earnings per share of 3.81 and the current share price of 68.96 USD.
What is the Short Interest ratio of AZN stock?
The outstanding short interest for AZN is 0.5% of its float.
AZN Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to AZN. When comparing the yearly performance of all stocks, AZN is one of the better performing stocks in the market, outperforming 70.94% of all stocks.
AZN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to AZN. While AZN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
AZN Financial Highlights
Over the last trailing twelve months AZN reported a non-GAAP Earnings per Share(EPS) of 3.81. The EPS increased by 5.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.11% | ||
| ROA | 6.17% | ||
| ROE | 16.3% | ||
| Debt/Equity | 0.79 |
AZN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 81% to AZN. The Buy consensus is the average rating of analysts ratings from 34 analysts.
For the next year, analysts expect an EPS growth of 15.68% and a revenue growth 15.89% for AZN